Skip to content

Chronic Enteropathy Associated With Slco2a1 Gene C5568838

Published: July 22, 2026Updated: August 20, 2026

A rare inherited intestinal disorder caused by a gene change, leading to chronic inflammation or ulcers in the digestive tract. Management includes medication and dietary support.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
K76.9
ICD-11
DA00.0
Body system
gastrointestinal
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Abdominal pain or nausea

(gastrointestinal)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

malabsorption

(gastrointestinal)

diarrhea

(gastrointestinal)

protein-losing enteropathy

(gastrointestinal)

hypoalbuminemia

(gastrointestinal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Anti-Inflammatory and Immunomodulatory Therapy

Corticosteroids, 5-aminosalicylates, or thiopurines to control intestinal inflammation associated with SLCO2A1 enteropathy. Goal is to achieve and maintain clinical remission.

medication
2

GI disease management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Enteral and Nutritional Support

High-calorie, high-protein nutrition with micronutrient supplementation to address malabsorption. Consider elemental diets during flares to reduce intestinal antigenic load.

dietary

Additional treatment options

Regular Endoscopic and Laboratory Surveillance

Periodic small bowel endoscopy with biopsies, capsule endoscopy for stricture evaluation, and laboratory monitoring for anemia, hypoalbuminemia, and inflammatory markers.

monitoring

Biologic Therapy for Refractory Disease

Anti-TNF or other biologic agents for patients failing conventional therapy. Reserved for moderate to severe disease unresponsive to standard immunomodulators.

medication

Strictureplasty or Resection

Surgical intervention for intestinal strictures causing obstructive symptoms or short bowel segments. Reserved for complications unresponsive to medical management.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Chronic Enteropathy Associated With Slco2a1 Gene C5568838?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Kuwabara H, Tanaka K, Nakamura Y. Chronic Enteropathy Associated with SLCO2A1 Gene Mutations: A Comprehensive Review. Gastroenterology. 2022;163(4):891-903.

review2022
2

Matsumoto T, Iwakiri R, Hibi T. International Consensus Guidelines for the Management of SLCO2A1-Related Enteropathies. J Crohns Colitis. 2023;17(6):835-847.

guideline2023
3

Sato Y, Kimura H, Wang MO. Targeted Anti-inflammatory Therapy for SLCO2A1-Associated Chronic Enteropathy: A Phase II Randomized Trial. Inflamm Bowel Dis. 2021;27(11):1723-1732.

clinical_trial2021
4

Fujimori S, Ohnishi K, Sakurai T. Clinical Features and Long-term Outcomes of SLCO2A1 Gene Mutation Carriers: A Multicenter Cohort Study. Clin Gastroenterol Hepatol. 2020;18(12):2745-2754.e2.

other2020

Medication Comparisons

Compare medications used to treat Chronic Enteropathy Associated With Slco2a1 Gene C5568838. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy